THX Pharma

ALTHX.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€714€1,199€2,105€5,520
Short-Term Investments€252€3,706€7,003€7,007
Receivables€582€5€18€42
Inventory€0€0€0€0
Other Curr. Assets€1,033€1,058€1,403€2,447
Total Curr. Assets€2,582€5,967€10,529€15,015
Property Plant & Equip (Net)€18€30€204€419
Goodwill€0€0€0€0
Intangibles€1,002€1,053€1,092€1,136
Long-Term Investments€138€187€229€320
Tax Assets€0€0€0€0
Other NC Assets€0€0€0€0
Total NC Assets€1,158€1,271€1,525€1,875
Other Assets€0€0€0€0
Total Assets€3,740€7,238€12,054€16,890
Liabilities
Payables€876€1,126€855€918
Short-Term Debt€1,152€1,182€1,284€1,138
Tax Payable€72€5€582€423
Deferred Revenue€0€5-€1,284-€1,138
Other Curr. Liab.€1,577€237€1,284€0
Total Curr. Liab.€3,678€2,555€2,721€1,341
LT Debt€1,719€2,461€3,605€5,327
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€0€0€0€40
Total NC Liab.€1,719€2,461€3,605€5,367
Other Liabilities€0€0€0€0
Cap. Leases€0€0€0€0
Total Liabilities€5,397€5,016€6,326€6,708
Equity
Pref Stock€0€4,888€0€6,894
Common Stock€2,134€1,940€1,337€1,256
Retained Earnings-€1,765-€6,828-€6,567-€8,150
AOCI€0-€6,828€2,596-€8,150
Other Equity-€2,026€7,110€8,363€17,076
Total Equity-€1,657€2,222€5,728€10,182
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€3,740€7,238€12,054€16,890
Net Debt€2,157€2,444€2,784€945